---
title: Treatment of SVT
---
# Treatment of SVT

Rhythm Acute Treatment Long-term Treatment
## Unstable
Acute: Cardioversion per ACLS
n/a
## ST
Acute: Treat underlying stressor(s)
Long-term: n/a
## AT
Acute: βB, CCB or adenosine; ? amiodarone
Long-term: radiofrequency ablation (RFA); βB or CCB, ± class IC/III AAD
## AVNRT or AVRT
Acute: Vagal maneuvers
Adenosine (caution in AVRT*)
CCB or βB, DCCV if other Rx fail
Long-term: For AVNRT (see next section for AVRT):
RFA. CCB, βB, or dig (chronic or prn)
± Class IC/III AAD (if nl heart)
## NPJT
Acute: CCB, βB, amiodarone
Long-term: Rx underlying dis. (eg, dig tox, ischemia)
## AF
Acute: βB, CCB, digoxin, AAD
Long-term: See “Atrial Fibrillation”
## AFL
Acute: βB, CCB, AAD
Long-term: RFA; βB or CCB ± class III AAD
## MAT
Acute: CCB or βB if tolerated
Long-term: Treat underlying disease. CCB or βB.
AVN ablation + PPM if refractory to meds

*Avoid adenosine & nodal agents if accessory pathway + pre-excited tachycardia, see below (Circ 2014;130:e199)
* Catheter ablation: high overall success rate (AFL/AVNRT ~95%, AVRT ~90%, AF ~70%)
complications: stroke, MI, bleeding, perforation, conduction block
